The quality of life of adults with attention deficit hyperactivity disorder: a systematic review
- PMID: 22808445
- PMCID: PMC3398685
The quality of life of adults with attention deficit hyperactivity disorder: a systematic review
Abstract
Objective: Across all medical specialties, quality of life has become an important measure of outcomes in both research and clinical settings. However, to date, there has not been a systematic review of the research relevant to quality of life in populations with adult attention deficit hyperactivity disorder. We approach quality of life in adult attention deficit hyperactivity disorder by answering the following questions: 1) What specific metrics are used to assess quality of life in adult attention deficit hyperactivity disorder? 2) What is the impact of adult attention deficit hyperactivity disorder on quality of life? 3) What effects do attention deficit hyperactivity disorder treatments have on quality of life? Searches of major electronic databases were conducted, and reference lists from the identified articles were searched for additional studies, with a focus on studies that utilized quality of life measures.
Design: Thirty-six relevant studies are included in our review.
Results: There are multiple unique measures currently used to measure quality of life in adult attention deficit hyperactivity disorder, ranging from general quality of life scales to those specifically designed for use in attention deficit hyperactivity disorder. Attention deficit hyperactivity disorder was found to significantly worsen the quality of life in adults. Treatment with atomoxetine and mixed amphetamine salts has shown beneficial effects on quality of life even in cases without symptomatology improvement.
Conclusion: Pharmacological treatment and early diagnosis have a positive impact on outcomes, longterm prognosis, and quality of life in adults with attention deficit hyperactivity disorder. Having multiple unique measures of quality of life have limited the direct comparison of different classes of attention deficit hyperactivity disorder medication treatments and future research should be aimed to address this.
Keywords: Adult attention deficit; hyperactivity disorder; quality of life.
Similar articles
-
Effectiveness of pharmaceutical therapy of ADHD (Attention-Deficit/Hyperactivity Disorder) in adults - health technology assessment.GMS Health Technol Assess. 2010 Sep 7;6:Doc13. doi: 10.3205/hta000091. GMS Health Technol Assess. 2010. PMID: 21289886 Free PMC article.
-
Current and Investigational Medication Delivery Systems for Treating Attention-Deficit/Hyperactivity Disorder.Prim Care Companion CNS Disord. 2016 Aug 18;18(4). doi: 10.4088/PCC.16r01979. Prim Care Companion CNS Disord. 2016. PMID: 27828696 Review.
-
Atomoxetine Treatment Strengthens an Anti-Correlated Relationship between Functional Brain Networks in Medication-Naïve Adults with Attention-Deficit Hyperactivity Disorder: A Randomized Double-Blind Placebo-Controlled Clinical Trial.Int J Neuropsychopharmacol. 2015 Sep 16;19(3):pyv094. doi: 10.1093/ijnp/pyv094. Int J Neuropsychopharmacol. 2015. PMID: 26377368 Free PMC article. Clinical Trial.
-
Quality of life of children with attention deficit hyperactivity disorder.Expert Rev Pharmacoecon Outcomes Res. 2005 Feb;5(1):95-103. doi: 10.1586/14737167.5.1.95. Expert Rev Pharmacoecon Outcomes Res. 2005. PMID: 19807563
-
Amphetamines for attention deficit hyperactivity disorder (ADHD) in adults.Cochrane Database Syst Rev. 2018 Aug 9;8(8):CD007813. doi: 10.1002/14651858.CD007813.pub3. Cochrane Database Syst Rev. 2018. PMID: 30091808 Free PMC article.
Cited by
-
Interactions between Obstructive Sleep Apnea Syndrome Severity, Obesity, Sex Difference and Attention-Deficit/Hyperactivity Disorder on Health-Related Quality of Life: A Non-Interventional Prospective Observational Study.Biomedicines. 2022 Jul 1;10(7):1576. doi: 10.3390/biomedicines10071576. Biomedicines. 2022. PMID: 35884881 Free PMC article.
-
The Paradoxical Clinical Course of Persons with Gambling Disorder and Comorbid Attention-Deficit/Hyperactivity Disorder (ADHD).J Gambl Stud. 2023 Dec;39(4):1723-1734. doi: 10.1007/s10899-023-10233-y. Epub 2023 Jul 4. J Gambl Stud. 2023. PMID: 37402115
-
Towards an ICF core set for ADHD: a worldwide expert survey on ability and disability.Eur Child Adolesc Psychiatry. 2015 Dec;24(12):1509-21. doi: 10.1007/s00787-015-0778-1. Epub 2015 Oct 1. Eur Child Adolesc Psychiatry. 2015. PMID: 26428005 Free PMC article.
-
Quality of Life and Caregiver Burden in Adult ADHD, Major Depressive Disorder, and Personality Disorders: A Cross-Sectional Study.Psychiatr Q. 2025 Jul 16. doi: 10.1007/s11126-025-10189-9. Online ahead of print. Psychiatr Q. 2025. PMID: 40670816
-
Insomnia Disorder in Adult Attention-Deficit/Hyperactivity Disorder Patients: Clinical, Comorbidity, and Treatment Correlates.Front Psychiatry. 2021 May 26;12:663889. doi: 10.3389/fpsyt.2021.663889. eCollection 2021. Front Psychiatry. 2021. PMID: 34122179 Free PMC article.
References
-
- Brod M, Johnston J, Able S, Swindle R. Validation of the adult attention-deficit/hyperactivity disorder quality-of-life scale (AAQoL): a disease-specific quality-of-life measure. Qual Life Res. 2006 Feb;15(1):117–129. - PubMed
-
- Adler LA, Sutton VK, Moore RJ. Quality of life assessment in adult patients with attention-deficit/hyperactivity disorder treated with atomoxetine. J Clin Psychopharmacol. 2006;26:648–652. - PubMed
-
- Rosler M, Casas M, Konofal E, Buitelaar J. Attention deficit hyperactivity disorder in adults. World J Biol Psychiatry. 2010;11(5):684–698. - PubMed
-
- Sentissi O, Navarro JC, De Oliveira H. Bipolar disorder and quality of life: impact of ADHD and substance abuse in euthymic patients. Psychiatry Res. 2008;30:36–42. - PubMed
LinkOut - more resources
Full Text Sources